| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 03/05/2008 | EP1894931A1 Triazole derivatives as kinase inhibitors |
| 03/05/2008 | EP1894930A1 Thiazole derivative |
| 03/05/2008 | EP1893715A2 Foaming agents containing fluorine substituted unsaturated olefins |
| 03/05/2008 | EP1893613A1 Hexahydro-pyrrolo-isoquinoline compounds for the treatment of cns disorders |
| 03/05/2008 | EP1893612A1 Pyrrolo [2, 3-b]pyridine derivatives as protein kinase inhibitors |
| 03/05/2008 | EP1893588A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 03/05/2008 | EP1893578A2 Novel piperidine carboxylic acid amide derivatives |
| 03/05/2008 | EP1893576A1 Treatment of protein folding disorders |
| 03/05/2008 | EP1893566A1 Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia |
| 03/05/2008 | EP1893245A2 Radiolabeled-pegylation of ligands for use as imaging agents |
| 03/05/2008 | EP1805175B1 Novel azaindole thiazolinones as anti-cancer agents |
| 03/05/2008 | EP1732541A4 Cyclic compounds |
| 03/05/2008 | EP1697362B1 Crf receptor antagonists and methods relating thereto |
| 03/05/2008 | EP1383733B1 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
| 03/05/2008 | EP0989993B1 Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 03/05/2008 | CN101137656A Crystal forms of an imidazole derivative |
| 03/05/2008 | CN101137655A Androgen receptor modulator compounds and methods |
| 03/05/2008 | CN101137376A Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use |
| 03/05/2008 | CN101134757A 稠合杂环化合物 Fused heterocyclic compounds |
| 03/05/2008 | CN101134019A Beta-carboline drug products |
| 03/05/2008 | CN100372851C Fused pyrimidine derivatives with CRF activity |
| 03/05/2008 | CN100372848C Spiroazacyclic compounds as monoamine receptor modulators |
| 03/05/2008 | CN100372847C Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via novel 1H-imidazo [4,5-C] quinolin-4-cyano and 1H-imidazo [4,5-C] quinolin-4-carboxamide intermediates |
| 03/05/2008 | CN100372846C Sulfonamido substituted imidazopyridines |
| 03/05/2008 | CN100372845C Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
| 03/05/2008 | CN100372844C 2-imidazo-benzothiazoles as adenosine receptor ligands |
| 03/05/2008 | CN100372536C Tablets quickly disintegrated in oral cavity |
| 03/04/2008 | US7339058 Process for the preparation of N-([1,2,4]triazolopyrimidin-2-yl)aryl sulfonamides |
| 03/04/2008 | US7338969 Acyclic, aromatic, heteroaromatic and cyclic ring containing amido-derivatives, useful as antibacterial agent; inhibition of formation of biofilms in personal hygiene articles, toileteries, cosmetics and in industrial settings like ship hulls, food processing systems, oil recovery or paper making plants |
| 03/04/2008 | US7338964 2-(2-oxa-3-azabicyclo[2.2.2]oct-5-en-3-yl)-6-amino-9-methyl-1-deazapurine; antiinflammatory, neuroleptic agent, antiallergens, neuroprotectant and antidepressant, cognition activator; improved bioavailability, without a ribose moiety; prodrugs with primary or secondary amino or hydroxy groups |
| 03/04/2008 | US7338963 blood coagulation factor (trypsin-like serine protease enzymes) inhibitor; 3-(4-methoxy-phenyl)-5-[4-(2-oxo-2H-pyridin-1-yl)-phenyl]-3,5,6,7-tetrahydro-[1,2,3]triazolo4,5-c]pyridin-4-one; anticoagulant; cardiovascular thromboembolic disorder transient ischemic attack, stroke, atherosclerosis |
| 03/04/2008 | US7338962 Spirocyclic heterocyclic derivatives and methods of their use |
| 03/04/2008 | US7338957 Diseases with abnormal activation of the Abl, BCR-Abl, Bmx, CSK, TrkB, FGFR3, Fes, Lck, B-RAF, C-RAF, MKK6, alpha and beta SAPK2 kinases; antiproliferative; pyrrolo[2,3-d]pyrimidine-7-carboxylic acid [3-phenylcarbamoyl-phenyl]-amides and pyrrolo[3,2-c]pyridine analogs |
| 03/04/2008 | US7338954 Compounds useful as motilin agonists and method |
| 03/04/2008 | US7338947 monocyte chemotactic proteins (MCP)-1 receptor antagonist or agonist; 2-{1-[(1,2-cis)-2-(4-Methylsulfanyl-benzoylamino)-cyclohexyl]-2-oxo-pyrrolidin-3-ylcarbamoyl}-4-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester; antiinflammatory agent, antiallergen; asthma, rheumatoid arthritis, atherosclerosis |
| 03/04/2008 | US7338721 Condensed polycyclic compound and organic light-emitting device using the same |
| 02/28/2008 | WO2008024692A1 N-oxide aryl sulfones and sulfoxides |
| 02/28/2008 | WO2008023720A1 Urea compound or salt thereof |
| 02/28/2008 | WO2008023161A1 2-methylmorpholine pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors |
| 02/28/2008 | WO2008022467A1 2-substituted azain doles and 2 substituted thienopyrroles, their precursors and novel processes for the preparation thereof |
| 02/28/2008 | WO2008022396A1 Fluorinated ligands for targeting peripheral benzodiazepine receptors |
| 02/28/2008 | WO2008003766A3 4-heter0cycl0alkylpyri(mi)dines, process for the preparation thereof and their use as medicaments |
| 02/28/2008 | WO2007076055A3 Compositions and methods comprising proteinase activated receptor antagonists |
| 02/28/2008 | WO2007042504A3 Compounds comprising a biological target recognizing part, coupled to a signal part capable of complexing gallium |
| 02/28/2008 | WO2007025043A3 Seven-membered ring nucleosides |
| 02/28/2008 | US20080051580 Process to Prepare Camptothecin Derivatives and Novel Intermediate and Compounds Thereof |
| 02/28/2008 | US20080051426 9-fluoro-3,3,6-trimethyl-2,3,4,7-tetrahydroindolo[2,3-c]quinolin-1-one; reacting substituted 1-oxo-2,3,4,7-tetrahydro-1H-5-oxonia-7-azabenzo[c]fluorene perchlorates, dihydrophosphates or tetrafluoroborates with ammonium hydroxide or ammonium acetate; ischemia-reperfusion injury; antidepressant |
| 02/28/2008 | US20080051414 Protein Kinase Inhibitors |
| 02/28/2008 | US20080051407 These compounds lack a 1,4-bridging group as found in the ecteinascidins; and, have at the C-1 position a substituent selected from an amino or hydroxy group, optionally protected or derivatized; anticarcinogenic agents |
| 02/28/2008 | US20080051387 Tetrahydropyrido[3,4-d]pyrimidines and related analogues |
| 02/28/2008 | CA2665804A1 Urea compound or salt thereof |
| 02/28/2008 | CA2661503A1 Inhibitors of 11.beta. -hydroxysteroid dehydrogenase type 1 |
| 02/28/2008 | CA2661436A1 Isoquinoline, quinazoline and phthalazine derivatives |
| 02/28/2008 | CA2660957A1 2-phenoxy pyrimidinone analogues |
| 02/28/2008 | CA2660951A1 Haloalkyl-substituted pyrimidinone derivatives |
| 02/28/2008 | CA2660169A1 Fluorinated ligands for targeting peripheral benzodiazepine receptors |
| 02/28/2008 | CA2659851A1 2-methylmorpholine pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors |
| 02/27/2008 | EP1891954A2 Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder |
| 02/27/2008 | EP1891951A1 Viral polymerase inhibitors |
| 02/27/2008 | EP1891950A1 Viral polymerase inhibitors |
| 02/27/2008 | EP1891078A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
| 02/27/2008 | EP1891076A1 Substituted tetrahydroquinolines |
| 02/27/2008 | EP1891069A1 2-phenyl substituted imidazol [4,5b]pyridine/ pyrazine and purine derivatives as glucokinase modulators |
| 02/27/2008 | EP1891068A1 Triazolopyridine derivatives as cannabinoid receptor 1 antagonists |
| 02/27/2008 | EP1891067A2 Androgen receptor modulator compounds and methods |
| 02/27/2008 | EP1891066A2 Compounds and compositions as protein kinase inhibitors |
| 02/27/2008 | EP1891050A1 New derivatives of pyrrolyltriazine together with methods for obtaining them and their use as protecting agents against uv radiation |
| 02/27/2008 | EP1891021A1 Aspartyl protease inhibitors |
| 02/27/2008 | EP1891011A1 Tetrahydroquinolines used in the form of modulators of mitotic motor-proteins eg5 |
| 02/27/2008 | EP1890696A2 Novel 3-spirocyclic indolyl derivatives useful as orl-1 receptor modulators |
| 02/27/2008 | EP1697356B1 Pyrido[2,3-d]pyrimidine-2,4-diamines as pde 2 inhibitors |
| 02/27/2008 | EP1678174A4 Process for preparing 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid |
| 02/27/2008 | EP1615904B1 Substituted benzosulphonamides as potentiators of glutamate receptors |
| 02/27/2008 | EP1581531B1 Pyridino¬2,3-d pyrimidine derivatives as selectiive kdr and fgfr inhibitors |
| 02/27/2008 | EP1506192B1 Substituted pyrroline kinase inhibitors |
| 02/27/2008 | EP1483266B1 Spiro compounds with npy antagonistic activity |
| 02/27/2008 | EP1268470B1 Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof |
| 02/27/2008 | EP1248612B1 Novel compounds and compositions as protease inhibitors |
| 02/27/2008 | CN101133060A Enzyme inhibitors |
| 02/27/2008 | CN101133055A Compositions and methods for treatment of cancer |
| 02/27/2008 | CN101130545A Method for preparing ester compound and analogue of the same |
| 02/27/2008 | CN101130541A Method for extracting and separating matrine and oxymatrine from trialkyl phosphine oxide inverse micellar solution |
| 02/27/2008 | CN100371336C Pyrrole derivatives for treating diseases of cytokine mediated |
| 02/27/2008 | CN100371329C Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases |
| 02/27/2008 | CN100370987C Tartrate salt of 5,8,14-triazatetracyclo [10,3,1,02,11.04,9]-hexzdeca-2(11),3,5,7,9-pentaene |
| 02/27/2008 | CN100370975C Inhibitors against the production and releaseof inflammator cytokines |
| 02/26/2008 | US7335779 Acyclic, aromatic, heteroaromatic and cyclic ring containing amido-derivatives, useful as antibacterial agent |
| 02/26/2008 | US7335774 Quinolinone derivatives |
| 02/26/2008 | US7335773 induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; exhibit antiviral and antitumor properties |
| 02/26/2008 | US7335772 1H-imidazo [4,5-c] quinolin-4-cyano and 1H-imidazo [4,5-c] quinolin-4-carboxamide intermediates |
| 02/26/2008 | US7335667 Use as anticancer agents, immunosuppressants for transplants or autoimmune diseases, or against immune reactions (e.g. contact dermatitis or diarrhea) caused by other drugs; e.g. 3-(3-[methyl(1H-pyrrolo[2,3-b]pyridin-4-yl)amino]piperidin-1-yl)-3-oxopropanenitrile |
| 02/26/2008 | US7335373 N-bromo- or chloro-substituted 7,7,9,9-tetramethyl-1,3,8-triazaspiro[4.5]decane-2,4-dione and 3-(3-trialkoxysilylpropyl) derivatives thereof; surface treatment to render antimicrobial |
| 02/21/2008 | WO2008021346A2 Pure paliperidone and processes for preparing thereof |
| 02/21/2008 | WO2008020902A1 Substituted spirocyclic cgrp receptor antagonists |
| 02/21/2008 | WO2008020611A1 Compound having pyridoindole ring structure having substituted pyridyl group attached thereto, and organic electroluminescence element |
| 02/21/2008 | WO2008020607A1 Phthalide derivative and salt thereof |
| 02/21/2008 | WO2008019968A1 Non-nucleoside reverse transcriptase inhibitors |
| 02/21/2008 | WO2008000951A3 Urea derivatives of tropane, their preparation and their therapeutic application |
| 02/21/2008 | WO2007149451A3 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 02/21/2008 | WO2007146831A3 Quinolone analogs derivatized with sulfonic acid, sulfonate or sulfonamide |